News
Zealand Pharma begins patient enrolment in phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes: Copenhagen, Denmark Saturday, April 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback